Diabetes mellitus (DM) is considered a public health problem. The initial treatment consists
of improving the lifestyle and making changes in the diet. When these changes are not …

The first UPLC method for simultaneous determination of empagliflozin, linagliptin and
metformin hydrochloride in the different combinations of their pharmaceutical dosage forms …

Abstract A reversed-phase RP-HPLC method was developed for the simultaneous
determination of metformin hydrochloride (MET), pioglitazone (PIO), and glimepiride (GLM) …

Pirfenidone (PFD) is the first pharmacological agent approved by the US Food and Drug
Administration (FDA) in 2014 for the treatment of idiopathic pulmonary fibrosis (IPF). The …

Metformin, an anti-diabetes drug, has been recently emerging as a potential “anti-aging”
intervention based on its reported beneficial actions against aging in preclinical studies …

A simple, rapid and sensitive liquid chromatography-tandem mass spectrometric (LC–
MS/MS) assay method has been developed and fully validated for the simultaneous …

A systematic and critical review was conducted on bioanalytical methods validated to
quantify combinations of antidiabetic agents in human blood. The aim of this article was to …

Bioanalysis of polar analytes using liquid chromatography–tandem mass spectrometry (LC-
MS/MS) remains a significant challenge because of their poor chromatographic retention on …

Simple, accurate and precise spectroflourometric and spectrophotometric methods have
been developed and validated for the determination of sitagliptin phosphate monohydrate …

Pioglitazone Hydrochloride (PG) is an insulin‐sensitizing drug and is indicated for the
treatment of type II diabetes. In this study, newly molecularly imprinted electrochemical …